Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

339 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Mobilization and transplantation of Philadelphia-negative peripheral-blood progenitor cells early in chronic myelogenous leukemia.
Carella AM, Cunningham I, Lerma E, Dejana A, Benvenuto F, Podestà M, Celesti L, Chimirri F, Abote M, Vassallo F, Figari O, Parodi C, Sessarego M, Valbonesi M, Carlier P, Prencipe E, Gatti AM, van den Berg D, Hoffman R, Frassoni F. Carella AM, et al. Among authors: podesta m. J Clin Oncol. 1997 Apr;15(4):1575-82. doi: 10.1200/JCO.1997.15.4.1575. J Clin Oncol. 1997. PMID: 9193355
Idarubicin, intermediate-dose cytarabine, etoposide, and granulocyte-colony-stimulating factor are able to recruit CD34+/HLA-DR- cells during early hematopoietic recovery in accelerated and chronic phases of chronic myeloid leukemia.
Carella AM, Frassoni F, Podestá M, Pungolino E, Pollicardo N, Ferrero R, Soracco M. Carella AM, et al. Among authors: podesta m. J Hematother. 1994 Fall;3(3):199-202. doi: 10.1089/scd.1.1994.3.199. J Hematother. 1994. PMID: 7530135 Clinical Trial.
Ph-negative blood progenitor cells (BPCs) can be recruited after chemotherapy and G-CSF during early hemopoietic recovery in patients at diagnosis of CML or pretreated only with hydroxyurea.
Carella AM, Frassoni F, Pollicardo N, Pungolino E, Podestà M, Giordano D, Ferrero R, Soracco M, Benvenuto F, Figari O. Carella AM, et al. Among authors: podesta m. Bone Marrow Transplant. 1994;14 Suppl 3:S34-7. Bone Marrow Transplant. 1994. PMID: 7535152 No abstract available.
High-dose chemo-radiotherapy followed by autologous Philadelphia chromosome-negative blood progenitor cell transplantation in patients with chronic myelogenous leukemia.
Carella AM, Chimirri F, Podestà M, Pitto A, Piaggio G, Dejana A, Lerma E, Pollicardo N, Vassallo F, Soracco M, Benvenuto F, Valbonesi M, Carlier P, Vimercati R, Prencipe E, Gatti AM, Ferrara RA, Incagliato M, Florio G, Frassoni F. Carella AM, et al. Among authors: podesta m. Bone Marrow Transplant. 1996 Feb;17(2):201-5. Bone Marrow Transplant. 1996. PMID: 8640167 Clinical Trial.
Autografting Ph-negative blood precursor cells in chronic myeloid leukaemia.
Frassoni F, Giordano D, Podestà M, Piaggio G, Benvenuto F, Pitto A, Figari O, Dejana A, Lerma E, Vassallo F, Sessarego M, Carella A. Frassoni F, et al. Among authors: podesta m. Bone Marrow Transplant. 1996 May;17 Suppl 3:S59-62. Bone Marrow Transplant. 1996. PMID: 8769704 Clinical Trial.
339 results